Juliette Roels

11PUBLICATIONS
157CO-AUTHORS
Molecular targetsInnate immunityHaematological tumoursGenome structure and regulationApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 05, 2026
The Hippo Pathway Is Dysregulated in Cancer-Associated Fibroblasts in Anti-PD-L1-Resistant Cancer.

Juliette Roels, Hamid Ghaedi, Jayaram Kancherla

|Jan 24, 2025
Different PD-L1 Assays Reveal Distinct Immunobiology and Clinical Outcomes in Urothelial Cancer.

Matthew D Galsky, Mark Kockx, Juliette Roels

|Mar 27, 2024
Tet2 is a tumor suppressor in the preleukemic phase of T-cell acute lymphoblastic leukemia.

Stien De Coninck, Juliette Roels, Béatrice Lintermans

|Jan 22, 2024
KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes.

Bimarzhan Assatova, Robert Willim, Christopher Trevisani

|Mar 07, 2023
SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry.

Bieke Decaesteker, Amber Louwagie, Siebe Loontiens

|Feb 11, 2023
Pre-Clinical Evaluation of the Hypomethylating Agent Decitabine for the Treatment of T-Cell Lymphoblastic Lymphoma.

Lien Provez, Tom Putteman, Mattias Landfors

Pageof 2

Frequent Collaborators

6 joint publications

Tom Taghon

5 joint publications

Pieter Van Vlierberghe

4 joint publications

Steven Goossens

3 joint publications

Anna Kuchmiy